Chemoinformaics analysis of Tetrahydropalmatine
| Molecular Weight | 355.434 | nRot | 4 |
| Heavy Atom Molecular Weight | 330.234 | nRig | 21 |
| Exact Molecular Weight | 355.178 | nRing | 4 |
| Solubility: LogS | -2.443 | nHRing | 2 |
| Solubility: LogP | 2.653 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 56.0478 |
| nHD | 0 | BPOL | 33.7342 |
| QED | 0.841 |
| Synth | 2.82 |
| Natural Product Likeliness | 0.866 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.831 |
| Pgp-sub | 0.928 |
| HIA | 0.003 |
| CACO-2 | -4.956 |
| MDCK | 0.0000253 |
| BBB | 0.988 |
| PPB | 0.830138 |
| VDSS | 1.145 |
| FU | 0.0852519 |
| CYP1A2-inh | 0.152 |
| CYP1A2-sub | 0.971 |
| CYP2c19-inh | 0.251 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.748 |
| CYP2d6-inh | 0.66 |
| CYP2d6-sub | 0.936 |
| CYP3a4-inh | 0.071 |
| CYP3a4-sub | 0.93 |
| CL | 10.615 |
| T12 | 0.716 |
| hERG | 0.253 |
| Ames | 0.149 |
| ROA | 0.514 |
| SkinSen | 0.189 |
| Carcinogencity | 0.062 |
| EI | 0.013 |
| Respiratory | 0.945 |
| NR-Aromatase | 0.659 |
| Antiviral | Yes |
| Prediction | 0.624827 |